Targeting head and neck cancer epigenetics with CRISPR-dCas9: An emerging therapeutic approach

Oral Oncol. 2022 Apr:127:105801. doi: 10.1016/j.oraloncology.2022.105801. Epub 2022 Mar 5.

Authors

Perumal Elumalai¹, Devaraj Ezhilarasan², Thangavelu Lakshmi¹

Affiliations

¹ Center for Transdisciplinary Research, Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu 600077, India.
² Center for Transdisciplinary Research, Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu 600077, India. Electronic address: ezhild@gmail.com.

PMID: 35255281
DOI: 10.1016/j.oraloncology.2022.105801

No abstract available

Publication types

Letter

MeSH terms

Clustered Regularly Interspaced Short Palindromic Repeats*
Epigenesis, Genetic
Gene Editing
Head and Neck Neoplasms* / genetics
Head and Neck Neoplasms* / therapy
Humans